234 related articles for article (PubMed ID: 32156599)
41. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
42. The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1.
Usmani SZ; Bona RD; Chiosis G; Li Z
J Hematol Oncol; 2010 Oct; 3():40. PubMed ID: 20977755
[TBL] [Abstract][Full Text] [Related]
43. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
[TBL] [Abstract][Full Text] [Related]
44. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
[TBL] [Abstract][Full Text] [Related]
45. Protective effects of tadalafil on damaged podocytes in an adriamycin-induced nephrotic syndrome model.
Tomita N; Hotta Y; Naiki-Ito A; Sanagawa A; Kataoka T; Furukawa-Hibi Y; Takahashi S; Kimura K
J Pharmacol Sci; 2022 Jun; 149(2):53-59. PubMed ID: 35512855
[TBL] [Abstract][Full Text] [Related]
46. Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.
Lydia A; Asanuma K; Nonaka K; Takagi M; Jeong KH; Kodama F; Asao R; Asanuma E; Prodjosudjadi W; Tomino Y
Am J Nephrol; 2012; 35(1):58-68. PubMed ID: 22189044
[TBL] [Abstract][Full Text] [Related]
47. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
[TBL] [Abstract][Full Text] [Related]
48. Palmitic Acid-Induced Podocyte Apoptosis via the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Liu T; Chen XM; Sun JY; Jiang XS; Wu Y; Yang S; Huang HZ; Ruan XZ; Du XG
Kidney Blood Press Res; 2018; 43(1):206-219. PubMed ID: 29490300
[TBL] [Abstract][Full Text] [Related]
49. Role of C/EBP-α in Adriamycin-induced podocyte injury.
Zhong F; Wang W; Lee K; He JC; Chen N
Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
[TBL] [Abstract][Full Text] [Related]
50. Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis.
Hosoe-Nagai Y; Hidaka T; Sonoda A; Sasaki Y; Yamamoto-Nonaka K; Seki T; Asao R; Tanaka E; Trejo JAO; Kodama F; Takagi M; Tada N; Ueno T; Nishinakamura R; Tomino Y; Asanuma K
Lab Invest; 2017 Nov; 97(11):1306-1320. PubMed ID: 28759006
[TBL] [Abstract][Full Text] [Related]
51. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells.
Wang SX; Ju HQ; Liu KS; Zhang JX; Wang X; Xiang YF; Wang R; Liu JY; Liu QY; Xia M; Xing GW; Liu Z; Wang YF
Biosci Biotechnol Biochem; 2011; 75(8):1540-5. PubMed ID: 21821931
[TBL] [Abstract][Full Text] [Related]
52. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
Jing X; Yang J; Jiang L; Chen J; Wang H
Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
[TBL] [Abstract][Full Text] [Related]
54. PU-H71, a novel Hsp90 inhibitor, as a potential cancer-specific sensitizer to carbon-ion beam therapy.
Li HK; Matsumoto Y; Furusawa Y; Kamada T
J Radiat Res; 2016 Sep; 57(5):572-575. PubMed ID: 27242340
[TBL] [Abstract][Full Text] [Related]
55. mPGES-1-derived PGE2 contributes to adriamycin-induced podocyte injury.
Yu J; Gong W; Wu Y; Li S; Cui Y; Ma Y; Zhang Y; Yang G; Huang S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F492-8. PubMed ID: 26739892
[TBL] [Abstract][Full Text] [Related]
56. Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation.
Yu J; Wu H; Liu ZY; Zhu Q; Shan C; Zhang KQ
Int J Mol Med; 2017 Oct; 40(4):1185-1193. PubMed ID: 28849106
[TBL] [Abstract][Full Text] [Related]
57. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.
Ren J; Lu X; Hall G; Privratsky JR; Robson MJ; Blakely RD; Crowley SD
Am J Physiol Renal Physiol; 2022 Feb; 322(2):F164-F174. PubMed ID: 34894725
[TBL] [Abstract][Full Text] [Related]
58. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
59. Paeoniflorin ameliorates Adriamycin-induced nephrotic syndrome through the PPARγ/ANGPTL4 pathway in vivo and vitro.
Lu R; Zhou J; Liu B; Liang N; He Y; Bai L; Zhang P; Zhong Y; Zhou Y; Zhou J
Biomed Pharmacother; 2017 Dec; 96():137-147. PubMed ID: 28972886
[TBL] [Abstract][Full Text] [Related]
60. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.
Wang J; Fu D; Senouthai S; You Y
Mol Med Rep; 2019 Dec; 20(6):5134-5144. PubMed ID: 31638199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]